Effect of Midwife-Led Pelvic Floor Muscle Training on Prolapse Symptoms and Quality of Life in Women with Pelvic Organ Prolapse in Ethiopia: A Cluster-Randomized Controlled Trial ================================================================================================================================================================================== * Melese Siyoum * Rahel Nardos * Biniyam Sirak * Theresa Spitznagle * Wondwosen Teklesilasie * Ayalew Astatkie ## Abstract **Back ground** Pelvic organ prolapse (POP) is a common condition that can significantly impact a woman’s quality of life. Pelvic floor muscle training (PFMT) is recommended as a first-line conservative treatment for prolapse, but evidence on its effectiveness from low-resource settings is limited. **Objectives** This study aimed to assess the effect of midwife-led pelvic floor muscle training on prolapse symptoms and health-related quality of life (HRQoL) among women with mild to moderate pelvic organ prolapse in Ethiopia. **Methods** A community-based, parallel-groups, two-arm cluster randomized controlled trial was conducted in Dale and Wonsho districts of Sidama Region, Ethiopia. Women with symptomatic POP stages I-III were randomized by cluster to receive either midwife-led PFMT plus lifestyle counseling (intervention group) or lifestyle counseling alone (control group). The primary outcomes were change in prolapse symptom score (POP-SS) and prolapse quality of life (P-QoL). Mixed-effects generalized linear model was used to determine the effect of PFMT on prolapse symptoms and P-QoL at 99% confidence level. Adjusted β coefficients were used as effect measures. The level of significance was adjusted for multiple comparisons. **Results** A total of 187 women were randomized to intervention (n=89) and control (n=98) arms. At sixth months, the intervention group showed significantly greater improvements both in prolapse symptoms and P-QoL with a mean change difference of -4.1 (99% CI: -5.38, -2.83) in prolapse symptoms; -11.48 (99% CI: -15.9, -7.1) in physical domain of P-QoL; -12.65 (99% CI: -19.3, -6.1) in psychological domain of P-QoL, and -9.47 (99% CI: -15.5, -3.5) in personal relationship domain of P-QoL. A significantly higher (84.2%) of women in the intervention group perceived their condition as “better” after the intervention as compared to 41.7% in control group. Women with earlier stages of prolapse (stage I and II) experienced higher benefits compared to those in stage III. **Conclusions** A midwife-led PFMT combined with lifestyle counseling significantly improves prolapse symptoms and quality of life in mild to moderate POP. This strategy can be integrated into the existing maternal and reproductive health programs to address POP in low-income settings where access to trained specialist is limited. **Trial registration** Pan African Clinical Trial Registry (PACTR202302505126575). Keywords * Pelvic organ prolapse * pelvic floor muscle training * cluster randomized trial * quality of life * Ethiopia ## Introduction Symptomatic pelvic organ prolapse (POP) is the descent of one or more of the uterus, cervix, anterior or posterior vaginal wall, or the vaginal apex from its normal position. This descent can be caused by deficient pelvic facia, or weakness in the ligaments or muscles that support the pelvic organs [1]. These structures can be affected by several risk factors including aging, vaginal childbirth, chronic constipation, hereditary connective tissue weakness, persistent elevated intra-abdominal pressure (IAP), menopause, and heavy lifting [2]. Pelvic organ prolapse (POP) is a prevalent condition affecting many women globally, with estimated prevalence rates varying widely from 1% to 65% [3, 4]. This broad range can be attributed to the challenges in accurately estimating prevalence, largely due to the differing methodologies employed in various studies. For instance, researchers may utilize a variety of symptom questionnaires and clinical examination techniques, leading to inconsistencies in the reported prevalence [3, 5]. Women with symptomatic POP present with a range of prolapse-related symptoms that are associated with the urinary, sexual, and anorectal symptoms [6]. It is evidenced that depressive symptoms and sexual function disorders are frequently associated with POP [7, 8]. In addition to disrupting daily functioning, these multifaceted symptoms of POP have significant negative impact on patients overall quality of life, body image and sexual function [8]. The severity of symptoms is directly related to the degree of prolapse. As the prolapse descends closer to or beyond the hymen, the symptoms become more frequent and bothersome [9, 10]. The current POP treatment options are either surgery or conservative managements approaches [11]. The conservative management options include pelvic floor muscle training (PFMT), pessary, life style modification, or watchful waiting, which are recommended as first-line options if the prolapse is not the indication for corrective surgery [2]. Conservative management has the advantage of causing fewer adverse effects and complications [12]. The existing evidence shows that PFMT has positive effect on prolapse symptom and severity [13]. Due to its effectiveness and safety, PFMT is indicated as a first-line treatment for women with mild to moderate POP [13]. PFMT improves prolapse symptoms by improving pelvic muscle strength, endurance, power, relaxation and combination of these parameters [1]. Awareness of POP and conservative treatment option is very poor among women [14] and healthcare professionals [15] even in high-income countries. To enhance the accessibility and variety of service for women, it is essential to understand various models of service delivery [16]. In low- and middle-income countries, evidence about the feasibility and effect of PFMT on prolapse symptoms and health-related quality of life (HRQoL) is limited. In Ethiopia, there is scarcity of evidence on the effectiveness of PFMT, and women often seek healthcare only at advanced stages of prolapse [17] when impact of PFMT may be limited. Additionally, the number of trained specialists such as urogynecologists or physical therapist are limited in Ethiopia. There are only 450 gynecologists registered in the Ethiopian Society of Obstetricians and Gynecologists out of which only 15 are urogynecologists and 13 are urogynecology fellows in 2021 [18]. In areas of the world with developed physical therapy training (PT) programs, (PT) management of pelvic organ prolapse is the gold standard for administering the service [19]. However, it is considered a sub-specialty within the profession and currently the Ethiopian Ministry of Health does not support specialty practice for the profession of Physical Therapy [20]. Fortunately, there is an abundance of trained Midwives in Ethiopia [21], who are potentially capable of learning how to deliver PFMT service. To address these challenges and improve access to the conservative management options, research into different models of PFMT service delivery is critical particularly in low resource settings. The aim of this study was to assess the effect of PFMT provided by trained midwives on prolapse symptoms and HRQoL among women with mild to moderate POP (stage I-III) in Sidama region, Ethiopia. Our hypothesis was that providing midwife-led PFMT monthly followed by three times per-day home-based exercise by participants for six months will improve prolapse symptoms and prolapse related quality of life. ## Methodology ### The Consolidated Standards of Reporting Trials (CONSORT) Checklist The CONSORT (Consolidated Standards of Reporting Trials) 2010 statement [22] was used to guide the reporting of this cRCT. The CONSORT checklist consists of a 25-item checklist that focuses on the key elements for reporting the design, conduct, analysis, and interpretation of RCTs. An extension to the CONSORT statement for reporting cluster randomized trials (cRCTs) [23] was also consulted. We have addressed all applicable items from the CONSORT checklist in the reporting of this cRCT (Supplementary File 1). ### Study area and period This study was conducted in the Health and Demographic Surveillance Site (HDSS) of Hawassa University, known as the Dale-Wonsho Health and Demographic Surveillance Site (D-W HDSS). D-W HDSS is located in the Dale and Wonsho districts of Sidama National Regional State of Ethiopia. The details of the study area have published elsewhere [24]. The enrollment period was open for eight months from 13 March to 28 October 2023. Each participant was followed for six months after enrollment. The last participants were enrolled on October 28, 2023 so the final follow-up visit was on April 27, 2024. ### Study design and participants A community-based, parallel-groups, two-arm, cluster-randomized controlled trial (cRCT) was conducted among women with symptomatic POP stages I-III in D-W HDSS. First, a baseline survey was conducted to determine the burden and risk factors of POP and to identify eligible cases [24]. Women aged over 18 years with at least one symptom of POP, confirmed as stages I-III using the standard POP-Q measure, were included in the study. The identified cases were then randomized by community clusters into intervention and control arms. Cluster randomization was preferred to minimize spillover of the intervention to the control arm and due to the feasibility of providing the intervention at group level (nearby health facility). The clusters were *kebeles* which are the smallest administrative units in Ethiopia, similar to neighborhoods or wards. They have a wide range of population sizes, from 500 to several thousand residents [25]. The surface area of *kebeles* varies depending on their location and population density, with those in densely populated urban areas being smaller compared to rural kebeles. Each *kebele* is further divided into smaller units called *gots* or *villages*. *Kebele* administrations are responsible for providing basic services, such as health, education, and infrastructure, to their residents. They also play a crucial role in population-based surveys and research studies in Ethiopia, often serving as the primary sampling units [26, 27]. Kebeles are organized into larger administrative divisions known as woredas (Districts). ### Sample size determination Sample size calculations were performed using Open-Epi version 3.1, based on the following assumptions: a 99% confidence level, 80% power, an exposed-to-unexposed ratio of 1, a POP-SS mean difference of 3.16 with a standard deviation of 4.78 in the intervention group, and a mean difference of 0.12 with a standard deviation of 3.86 in the control group over six months [15]. This calculation yielded a required sample size of 96, adjusted for an anticipated 16% refusal and loss to follow-up [15], resulting in an individual-based total sample size of 111.34. This sample size was utilized for all outcomes since we were unable to determine the effect of pelvic floor muscle training (PFMT) on quality of life as measured by the Prolapse Quality of Life Questionnaire. The decision to adjust the confidence level to 99% was based on the adjusted level of significance to 0.0125 than the usual p-value of 0.05 to account for multiple comparisons across various outcomes (POP-SS and three distinct domains of P-QoL). To determine the minimum number of clusters required, the individual-based sample size was multiplied by the intra-cluster correlation coefficient (ICC). Since there was no reported ICC from earlier studies, we used an ICC of 0.03, which was suggested as estimated fairly typical value of the Intra-Cluster Correlation (ICC) [28, 29]. This calculation indicated a need for 1.67 clusters per arm. To ensure adequate power [30, 31], a total of eight clusters were selected randomly from the 12 available clusters in the D-W HDSS. After adjusting for cluster effects with a variance inflation factor (VIF) of 1.39, the total effective sample size increased to 155, resulting in an expected average of 19.4 participants per cluster. However, during enrollment, a slightly higher number of eligible cases was identified in each cluster. Excluding these additional participants was deemed unethical, and alternative treatment options could not be provided due to the cRCT design. Furthermore, it was believed that including all eligible cases would be manageable and enhance the study’s power [28, 29]. Consequently, all eligible cases were included, raising the total sample size from 155 to 187 participants. ### Randomization and concealment The study site, D-W HDSS, comprises eight kebeles from Dale district and four kebeles from Wonsho district. These were stratified into two strata based on their geographical location (Dale and Wonsho districts). Stratifying on location reduces stratum variability and helps to ensure that they are balanced across study arms [30, 31]. To improve similarity across treatment and control groups, a balanced number of clusters from each stratum were assigned to each arm. First all eligible clusters in each district were listed and assigned a unique identifier number. Then, a lottery method was used to select two of four clusters from Wonsho district and randomly assigned to each arm. Similarly, six of eight clusters from Dale districts were selected and three clusters were assigned to each arm randomly by lottery method. To reduce the risk of spillover-effect of the intervention, the interventional and control clusters were separated by a buffer zone [30], and when it is impossible due to the limited number of clusters in the D-W HDSS, adjacent clusters were assigned to the same arm. Finally, all eligible study participants from each cluster identified during the baseline survey were included in the study (Figure 1). ![Figure 1:](http://medrxiv.org/http://medrxiv.stage.highwire.org/content/medrxiv/early/2024/08/31/2024.08.30.24312827/F1.medium.gif) [Figure 1:](http://medrxiv.org/content/early/2024/08/31/2024.08.30.24312827/F1) Figure 1: Randomization and Sampling procedure used to assess the effect of pelvic floor muscle training on prolapse symptoms and quality of life in Sidama Region, Ethiopia, August 2024. Allocation concealment was conducted by staff of D-W HDSS at Hawassa University. To ensure unbiased allocation, the lottery method was performed by an independent researcher who was not involved in the recruitment, intervention, or outcome assessment processes. Two staff members of Yirgalem Hamline Fistula center, who performed pelvic examination to determine POP stage, recruited eligible participants of for intervention. ### Blinding (Masking) The participants in the intervention group were aware that they were receiving the PFMT program but they were not aware of the control group. Similarly, the control group knew that they are receiving life style counselling but they are not aware of the intervention group. The same is true for the healthcare providers delivering the counselling. Moreover, the outcome assessors, who collected data at the end of intervention, were blinded to the participants’ treatment allocation. ### Description of the intervention Each cluster in the study area is served by its own health posts, staffed by health extension workers, while five or more clusters are supported by a single health center. These health centers are staffed by formally trained healthcare professionals, including midwives. The current intervention was implemented at these health centers due to their capacity to deliver the training and their geographical accessibility to participants, especially when compared to hospitals. In this study area, all health centers have at least three degree-holding midwives responsible for providing antenatal, delivery, and postnatal care. Each health center is equipped with various rooms, including delivery rooms, cervical cancer screening rooms, and outpatient rooms, which are suitable for conducting the Pelvic Organ Prolapse Quantification (POP-Q) assessments and ensuring confidentiality during individual counseling sessions. From each selected health facility, two female midwives were trained either on pelvic floor muscle training and how to counsel patients, or only on how to counsel for life style modification based on their pre-allocated health facility. The training that included education on theory, simulation, and video aids was given by a fellowship trained urogynaecologist. Then, the trained midwives administered the intervention to the women assigned in the intervention arms. Women who were assigned to intervention received pelvic floor muscle training and prolapse lifestyle advice focusing on risk factors for POP such as constipation, chronic coughing, heavy lifting, and other medical conditions. The control group received only lifestyle modification. In the interventional group, the pelvic examiners link eligible women to the assigned midwife with the POP-Q findings. Then, at the initial visit, women were informed by midwives about the stage of POP they had and type of prolapse (anterior, posterior, or central) which was explained in a private room. Then the advantage of pelvic floor muscle exercise, and how it works, the detail of the exercise and follow-up schedule were explained in detail at group level in a private room for 40-60 minutes. They were trained to sit or lie comfortably, train pelvic muscles with 10 times 10-second maximum holds, and 10 fast contractions [15, 32]. They were instructed to repeat this at least three times per day (morning, afternoon, and night) [15, 33]. Women were taught how to precontract the pelvic floor muscles against increases in intra-abdominal pressure (Knack exercise). They were trained to exercise 10 long squeezes and lift contractions, each held for 10 seconds, allowing time between the squeeze to relax and lower the muscle for up to 5 seconds. The long squeezes were followed by10 short squeezes. Women were advised to try to feel the releasing and relaxing of the squeeze after 10 short squeezes, and finally, to do a squeeze with a light cough for 10 times. The long squeezes were for 10 seconds each and the 10 quick squeezes for 1-2 seconds each. To help participants correctly identify and contract their pelvic floor muscles, the participants in the intervention group received pelvic floor muscle training with internal digital biofeedback administered by the trained midwives. During the individual training sessions, midwives used various verbal cues and analogies. For example, participants were instructed to "imagine you are trying to stop the flow of urine or hold back gas. Squeeze as though you are trying to slow down or stop your urine mid-stream" [34]. This relevant analogy helped participants visualize the specific action they needed to perform. Throughout the exercises, midwives provided descriptive feedback to guide participants. They would say things like, "As you squeeze, focus on lifting the muscles around your vagina and anus upwards. You should feel a tightening and lifting sensation" [32, 34, 35]. This encouraged participants to be aware of the specific muscles being engaged during the contractions. The detail of the counselling was provided using a *Sidaamu Afoo* (local language) version of a the PROPEL realist evaluation guideline [33]. They were appointed to attend five visits (at weeks 0, 2, 6, 10, and 15) at a nearby health facility. The appointment frequency was adapted from the United Kingdom National Health Service (NHS) [36]. Initial appointments were scheduled closely together to reinforce correct exercise techniques and ensure participants fully understood all the advice provided. Subsequently, appointments were spaced further apart to promote independent home exercise. A 15-weeks intensive training was recommended to get adequate muscle strength [37]. The change in prolapse symptoms and health related quality of life were analyzed at six months. ### Data Collection Tools and Measurements Our primary outcomes were pelvic organ prolapse symptoms and health-related quality of life (HRQoL). The POP-SS was measured by the *Sidaamu Afoo* version of the pelvic organ prolapse symptom score (POP-SS) questionnaire [38]. The psychometric properties of the questionnaire have been evaluated in the same setting and found to have acceptable reliability and validity. It is a patient reported-outcome measure that contain seven items with five Likert-scale ranging from 0 to 4, with a possible total score of 0 to 28 (the higher score representing worse symptom) [39]. Health-related quality of life was measured by using the prolapse quality of life (P-QoL) questionnaire translated from the Amharic version [40]. While the original version has 20 items with nine domains [41], in a previous work designed to adapt the P-QoL locally (*to Amharic version*), the dimensions have been condensed into three: physical function (including General health perception (GHP), prolapse impact (PI), role (RL), physical (PL) and social limitation (SL), and severity measures (SM)); psychological function (including emotional disturbances (EMO) and sleep/energy disturbances (SE)); and personal relationships ((PR). Each domain is related to a particular aspect of QoL, and scores in each domain range from 0 to 100, the higher score indicating poor quality of life. This tool has previously been validated in a similar context (northern Ethiopia). The secondary outcome, women’s perceived change in prolapse, was evaluated using the patient global impression of change index (PGI-I), a seven-point Likert scale (1 = very much better to 7 = very much worse) [42]. In this study, patients were classified as improved if they scored 1, 2, or 3 on the PGI-I scale, no change if they scored 4 and worse if they scored 5, 6 or 7. Intervention adherence was measured in terms of attendance at appointments [15] and the amount of exercise women reported at follow-up time. Women’s adherence to training protocol is considered adequate when they complete at least 80% of the training sessions given by midwives [43]. ## Data Collection Procedures The details of the baseline data collection procedures and tools have been published elsewhere [24]. All tools were translated from English and Amharic into the local language (*Sidaamu Afoo*). The baseline data about sociodemographic characteristics and prolapse symptoms were collected through face-to-face interview with women at their home by eight first degree nurses using electronic data collection forms prepared using Kobo tool box. The women were subsequently invited for pelvic examination in a nearby health center to confirm their prolapse status and degree of prolapse by using the POP-Q [44]. The POP-Q was performed by staff members of Yirgalem Hamlin Fistula Center who have special training on Fistula and POP identification. Then women with symptomatic POP stages I-III were interviewed how much the prolapse had affected their quality of life using P-QoL tool. The detail POP-Q procedures and data quality assurance method was published elsewhere [24]. At three months and six months of intervention, four first degree nurses went to the house of the study participants and collected the data through face-to-face interviews. The data collection tool included the POP-SS and P-QoL questionnaires used at baseline, PGI-I change and questions used to assess their adherence to training protocol [43]. ### Statistical analysis All data analyses accounted for the complex sampling design, which included stratification by district (Dale and Wonsho), clustering by kebele, and weighting for unequal probability of selection. The weighting variable was the product of cluster and household selection weights, normalized by dividing each unit’s survey weight by the unweighted average of the survey weights. Categorical variables were summarized as frequencies and percentages, while continuous variables were summarized using means and standard deviations or medians and interquartile ranges. The analysis was based on the intention-to-treat principle. In practice, all participants adhered to their allocated treatment and completed the follow-up as scheduled. Although the intervention was randomly assigned at the cluster level, outcomes were evaluated at the individual level. To compare the primary outcomes at six months, we fitted a multilevel mixed-effects generalized linear model (MEGLM) to the change from baseline in POP-SS and each domain of HRQoL at three and six months. The model included fixed effects for treatment group, time, and other relevant covariates, as well as a random intercept for patients within centers and a random slope for time within patients. MEGLM was chosen for its flexibility and robustness needed to accurately model the complex and varied data structures often found in cRCT leading to more reliable and interpretable results [45]. The difference between intervention and control group was estimated by mean change from baseline at six months. Bonferroni correction for multiple measurement [46] was used to adjust level of significance to 0.0125 as we measured effect of PFMT on four outcomes (POP-SS and three domains of HRQoL). Then a mean change difference between the intervention and control arms was presented with 99% confidence interval and p-values. This adjustment is crucial for maintaining statistical rigor and minimizing the risk of Type I errors in the analysis [46]. To evaluate model fit, we initially fitted a null model for each outcome variable (POP-SS and the three domains of Prolapse Quality of Life (P-QoL)), incorporating random effects for both cluster and participant ID. We calculated the intraclass correlation coefficient (ICC) to determine the proportion of variance in the outcome attributable to the clustering structure, which was found to be 4% and less in this study. Subsequently, we fitted models that included the intervention variable along with the outcome variables individually. This step allowed us to assess the impact of the intervention on each outcome. To control for effect of confounders and effect modifiers, for each model with added predictors, we evaluated model fitness using the Pseudo Log-Likelihood values for model fitness and Adjusted Wald Test for significance of predictors. Higher (less negative) Pseudo Log-Likelihood values indicate better model fit and significant Wald test indicates importance of the predictors [47]. This approach allowed us to identify the most appropriate models for each outcome. Residual analysis was done to assess homoscedasticity and normality of residuals by using histogram. The random intercept was insignificant and the model without the cluster variable provided a better fit to the data compared to the model accounting for clustering (P < 0.001). Therefore, the simpler model without the cluster variable was used for the final analysis. However, to account for repeated measures at the individual level, the participant identification code was maintained in the final model. The data set on which the analysis based was provided as a supplementary file 2. ### Trial Registration The trial was registered at the Pan African Clinical Trial Registry ([https://pactr.samrc.ac.za](https://pactr.samrc.ac.za)) database, with the registration number PACTR202302505126575. ## Results ### Trial profile A total of 187 eligible women were randomized to the intervention group (n = 89) or the control group (98). All of them completed the follow-up and completed the questionnaire at three and six months. The age of participant ranged from 19 to 80 years with the median of 36 years (IQR: 31–50). All were parous, with a median of 4 childbirths (IQR: 4–6). The median hours of daily heavy lifting work were 4 hours (IQR: 3–5). The most common stage of prolapse was Stage II (64.4%). The median duration of feeling prolapse symptom was 48 (30 -60) months with the minimum of five months and maximum of 20 years. At baseline, a slightly higher number of women in menopause, family history of prolapse, and history of home birth were observed in the intervention group. The mean baseline POP-SS and quality of life domain scores were almost similar across the groups. Almost half 92 (49%) of the participants had prolapse of multiple vaginal compartments; whereby 161 (86%) had anterior prolapse, 113 (60.3%) had posterior prolapse and 28 (14.8%) had apical prolapse. Overall, the intervention and control arms were balanced in terms of most characteristics at baseline. Detailed sociodemographic characteristics are presented in Table 1. View this table: [Table 1:](http://medrxiv.org/content/early/2024/08/31/2024.08.30.24312827/T1) Table 1: Sociodemographic and Clinical Characteristics of Trial Participants at Baseline in Sidama Region, Ethiopia (August 2024) (n = 187) ### Adherence and Follow-up All study participants adhered strictly to their allocated treatment and completed the follow-up as scheduled. No participants changed their allocation, missed follow-up appointments, or failed to complete the treatment regimen. Consequently, while our analysis framework was based on the intention-to-treat principle, the actual adherence and follow-up were perfect, ensuring that all participants were analyzed according to their initial allocation. ### Prolapse Symptoms and Quality of Life at Six Months Women in the intervention group reported significant improvements in prolapse symptoms and across all domains of prolapse-related quality of life (P-QoL) at six months. In the unadjusted model, the most substantial improvement was observed in the physical function component of the P-QoL, with a mean change difference of -11.48 (99% CI: -15.9, -7.1), indicating a large effect size. Moreover, a significantly higher number of women in the intervention group reported their condition as “better” after the intervention compared to the control group (Table 2). View this table: [Table 2:](http://medrxiv.org/content/early/2024/08/31/2024.08.30.24312827/T2) Table 2: Effect of pelvic floor muscle training on prolapse symptom and prolapse quality of life, Sidama Region, Ethiopia, August 2024. All prolapse symptoms were significantly improved from the baseline for the intervention group but in the control group, “a feeling of vaginal discomfort/pain and something passing through vagina remained persistent”. Compared to the control groups, a significant reduction in POP-SS scores were observed in two items “a feeling of vaginal discomfort/pain and something passing through vagina. ### Effect modification and effect of other covariates on pelvic organ prolapses and quality of life We observed no significant interactions between the intervention arms and any variable including stage of prolapse, duration of symptom, occupation, educational status and site of prolapse. However, women in the stage I and II prolapses experienced more marked improvements compared to stage III prolapse both in prolapse symptom and quality of life. Women with higher POP-SS scores, indicating more severe symptoms, experienced less improvement in the physical domain of quality of life compared to those with lower scores. The analysis showed that as the severity of prolapse symptoms increased, the associated improvements in the physical domain of the Prolapse Quality of Life (P-QoL) questionnaire were diminished. Moreover, after adjusting for the severity of prolapse symptoms and the stage of prolapse, the effect of PFMT on the physical domain of quality of life was slightly diminished but showed increased effects in the personal relationship and psychological domains (Table 3). View this table: [Table 3:](http://medrxiv.org/content/early/2024/08/31/2024.08.30.24312827/T3) Table 3: Pelvic floor muscle training effect modifiers on prolapse symptom and quality of life, Sidama Region, Ethiopia, August 2024. ### Adverse Events No adverse events were observed. ## Discussion This study showed that midwife-led pelvic floor muscle training combined with lifestyle counselling significantly improves prolapse symptoms with a mean change difference of -4.1 in prolapse symptom score and each domain of prolapse-quality of life with a mean change difference of -11.48 in the physical domain, -9.47 in the personal relationship domain, and - 12.65 in the psychological domain. A significantly higher number of women in the intervention group perceived their condition as “better” since the intervention compared to the control group, highlighting the subjective benefit of PFMT. The effects of PFMT were more noticeable in women with prolapse stage-I with a mean change difference of -5.08 and stage II with a mean change difference of -3.06 as compared to stage III in reducing POP-SS. Similar effect was observed on each domain of P-QoL. In addition, severity of prolapse symptoms was associated with physical function of the P-QoL domain with a mean change difference of 0.6 compared to minor prolapse symptoms indicating that more severe symptoms were linked to less improvement. The results of the present study align with existing literature from developed countries indicating the benefit of PFMT for the treatment of POP symptoms and quality of life. A multicenter Randomized Controlled Trial (RCT) study from 25 centers (United Kingdom, Dunedin, New Zealand and Australia) conducted by Hagen et al. [15] showed that PFMT led to significant reduction in POP symptoms and improved quality of life. A single center RCT and systematic review of RCT findings also show that PFMT is effective in reducing POP-symptoms, prolapse stage and quality of life in women with POP-Q stage I-III [4]. Based on the findings of those studies, the Cochrane reviews [48, 49] and national institute for health and care excellence (NICE) guidelines [50] recommended PFMT as a first line of treatment for incontinence and pelvic organ prolapse, to be provided at primary care facilities [51]. Our finding extends these findings and recommendations to a low-income setting which is of a different cultural and health care context, highlighting the universal applicability of PFMT across diverse settings. Moreover, the observed difference in mean change is statistically significant and clinically important as it exceeded the minimally important change of 1.5 for POP-SS [52]. Again, a remarkable improvement was reported on “a feeling of vaginal discomfort/pain and protruding mass through vagina” which are the major indicators for prolapse surgery and regarded as the most crucial treatment target [53]. The significant reduction in these key symptoms underscores the importance of PFMT. These two symptoms are closely linked to the physical support provided by the pelvic floor muscles. Strengthening these muscles through PFMT may lead to a more noticeable reduction in these specific symptoms compared to others that may be less directly influenced by muscle strength or may involve more complex physiological changes. The existing evidence shows that the improvement in POP-SS and P-QoL after PFMT can be attributable to several mechanisms. Overall, PFMT strengthens the pelvic floor muscle, providing better support for pelvic organs which can reduce/stop degree of prolapse and alleviate associated symptoms like vaginal bulging, discomfort, and lower back pain [43, 54]. Enhanced muscle strength also improves urinary and bowel control, reducing symptoms like straining to urinate and difficulty emptying the bowel [54, 55]. The contraction and relaxation of pelvic floor muscles during PFMT promote blood flow to the pelvic region and stimulate the nerves in the area, improving nerve function [56]. In the present study, women with stage I and II prolapses reported more noticeable improvements compared to those with stage III prolapses indicating that the earlier stage of prolapse are more responsive to PFMT. Borello-France and colleagues reported that women with stage II prolapse were better able to elevate their pelvic floor than those with stage III or IV [57]. Severity of prolapse symptoms was associated with physical function suggesting that more severe POP-SS causes less improvement. After adjusting for prolapse stage and symptom severity, the effect of PFMT remained significant with slightly reduced effect on physical function but slightly increased effects on personal relationship and psychological domains. The findings of this study have important implications for clinical practice and public health policy in low-resource settings. The first implication is that the result suggest that midwife-led PFMT can be considered as a first-line conservative treatment for mild to moderate stage of prolapse in all settings especially in resource limited settings where access to specialized care is limited. This can be integrated in to the existing maternal and reproductive health programs. The second implication is that in settings where the number of urogynecologists/pelvic physiotherapy expert is limited, like the current Ethiopian context, training midwives to deliver PFMT and lifestyle counseling is feasible and effective to address prolapse symptoms and improve quality of life among women with POP. We recognize that the most recommended form of PFMT is supervised training given by a physiotherapist or urogynecologists who have greater in-depth knowledge [1]. However, this is not feasible in low-resource settings due to shortage of trained specialists (only less than 28 urogynecologists in Ethiopia). It was evidenced that nurse-delivered PFMT have comparable effect with those delivered by specialists when implemented properly [58, 59]. In the present study, the observed mean change difference was relatively larger and the compliance/adherence to training was better compared to previous studies. This adherence might be because midwives working in the nearby health facility and the women in the intervention know each other, and that may create trust and acceptability. This is a nice model that can be scaled up in other settings including high income countries. This study has its own strength and limitations. Among others, the key strength of the study includes the rigorous cluster randomized controlled design which enhances the internal validity of the finding, high adherence rate and complete follow-up which ensure the reliability of the results. The use of validated and culturally adapted measurement tools ensures the relevance and accuracy of the collected data, and also the use of a complex survey design, which accounts for the clustered nature of the data, enhances the potential generalizability of the results to the target population. Above all, to our knowledge, this study is the first to evaluate effect of PFMT on prolapse symptoms in Ethiopia. However, some limitations should be considered. The reliance on self-reported adherence to PFMT and symptom improvement may introduce performance bias since the participants were not blinded to the intervention. This participants’ knowledge of their treatment allocation may influence their reported outcomes that could lead to higher treatment effect and reported adherence rate. ## Conclusion Midwife-led pelvic floor muscle training combined with lifestyle counseling significantly improves prolapse symptoms and quality of life across all domains in women with pelvic organ prolapse. The observed treatment effects were significant and clinically important. The effects of PFMT were higher in women with earlier stage of prolapse. Move over, in settings with shortage of urogynecologists, training midwives to deliver PFMT and lifestyle counselling is a feasible and effective approach to improve prolapse symptoms and quality of life. Future studies should incorporate objective measures of adherence and explore long-term effects. Healthcare organizations should advocate and endorse training of midwives and other healthcare providers to deliver PFMT. ## Declarations ### Ethical Considerations and consent to participate This study was conducted in accordance with the principles of the Declaration of Helsinki. Ethical approval was obtained from Institutional Review Board of Hawassa University, College of Medicine and Health Sciences (Ref. No. IRB/157/14). Written informed consent was obtained with provisions for participants unable to read and write to sign with their index fingers, confirming that the consent had been read to them. Given the sensitive nature of the condition, data regarding self-reported prolapse symptoms were collected in a private location within the participants’ homes. Pelvic examinations were conducted in delivery rooms to ensure participants’ physical privacy, while lifestyle counseling and pelvic floor muscle training took place in private rooms. All study information was kept confidential, with participants assigned codes to replace their names and personally identifying information. Access to the key linking these codes to individual identities was restricted to the principal investigator. The risks to participants were minimal. While there was potential for psychological distress related to the pelvic examination, as well as temporary discomfort during physical exams and inconvenience from follow-up visits, these risks were mitigated by allowing participants to withdraw from the study at any time during the consent process. The research team provided travel costs and time compensation, equivalent to approximately four dollars (200 Ethiopian Birr), to the participants. During baseline data collection, around 26 participants with stage IV prolapse were referred to the Yirgalem Hamlin Fistula Center for further management. After the study’s completion, women with symptomatic stage III prolapse in the control group linked with the Yirgalem Hamlin Fistula Center for additional care. ### Consent for publication Not Applicable ### Authors contribution Melese Siyoum: Conceptualization, methodology, fund acquisition, mentorship, formal analysis, validation, writing original draft, review and editing on final version. Rahel Nardos: Methodology, mentorship, fund acquisition, validation, reviewing and editing the manuscript Biniyam Sirak: Methodology, fund acquisition, validation, reviewing and editing the manuscript Theresa Spitznagle: Methodology, validation, reviewing and editing the manuscript Wondwosen Teklesilasie: Methodology, validation, reviewing and editing the manuscript Ayalew Astatkie: Conceptualization, methodology, formal analysis, validation, reviewing and editing the manuscript All authors read and approved the final manuscript ## Data Availability All relevant data are within the manuscript and its Supporting Information files. ## Funding The payment for data collectors, participant transportation, and field supervisor per-diem was sponsored by Hawassa University, University of Minnesota, Worldwide Fistula Fund and Maternal Health Fund. The funders have no role in designing the study, intervention, data management and publication. ## Conflict of interest All authors declare that they have no conflict of interest ## Availability of data and materials The dataset used for this study is available within the manuscript and as supplementary file ## Acknowledgment We would like to thank our sponsors (Hawassa University, University of Minnesota, Worldwide Fistula Fund, and Maternal Health Fund) for their financial support. The study participants and data collectors also deserve gratitude. We also thank Dr. Karen Gold and Joseph Kinahan (Maternal Health Fund), Soja Orlowski (Worlwide Fistula Fund), Katie Brown (University of Minnesota) and Alemu Tamiso (Hawassa University) for their facilitation in transferring funds. Yirgalem Hamlin Fistula Center, Health centers in the study area and Mr. Rekiku Fikre (Hawassa University) deserve acknowledgement for facilitating transportation service support in material. * Received August 30, 2024. * Revision received August 30, 2024. * Accepted August 31, 2024. * © 2024, Posted by Cold Spring Harbor Laboratory This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license ## References 1. 1.Bo K, Frawley HC, Haylen BT, Abramov Y, Almeida FG, Berghmans B, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. International urogynecology journal. 2017;28:191–213. 2. 2.Bø K, Anglès-Acedo S, Batra A, Brækken IH, Chan YL, Jorge CH, et al. International urogynecology consultation chapter 3 committee 2; conservative treatment of patient with pelvic organ prolapse: pelvic floor muscle training. International urogynecology journal. 2022;33(10):2633–67. 3. 3.Hadizadeh-Talasaz Z, Khadivzadeh T, Mohajeri T, Sadeghi M. Worldwide Prevalence of Pelvic Organ Prolapse: A Systematic Review and Meta-Analysis. Iranian Journal of Public Health. 2024. 4. 4.Brown HW, Hegde A, Huebner M, Neels H, Barnes HC, Marquini GV, et al. International urogynecology consultation chapter 1 committee 2: Epidemiology of pelvic organ prolapse: prevalence, incidence, natural history, and service needs. International Urogynecology Journal. 2022:1–15. 5. 5.Barber MD, Maher C. Epidemiology and outcome assessment of pelvic organ prolapse. International urogynecology journal. 2013;24:1783–90. 6. 6.Ward RM, Edwards DRV, Edwards T, Giri A, Jerome RN, Wu JM. Genetic epidemiology of pelvic organ prolapse: a systematic review. American journal of obstetrics and gynecology. 2014;211(4):326–35. 7. 7.Ai F, Deng M, Mao M, Xu T, Zhu L. Depressive symptoms screening in postmenopausal women with symptomatic pelvic organ prolapse. Menopause. 2018;25(3):314–9. [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F08%2F31%2F2024.08.30.24312827.atom) 8. 8.Lowenstein L, Gamble T, Deniseiko Sanses TV, Van Raalte H, Carberry C, Jakus S, et al. Sexual function is related to body image perception in women with pelvic organ prolapse. The journal of sexual medicine. 2009;6(8):2286–91. 9. 9.Ellerkmann RM, Cundiff GW, Melick CF, Nihira MA, Leffler K, Bent AE. Correlation of symptoms with location and severity of pelvic organ prolapse. American journal of obstetrics and gynecology. 2001;185(6):1332–8. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1067/mob.2001.119078&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=11744905&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F08%2F31%2F2024.08.30.24312827.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000172905900014&link_type=ISI) 10. 10.Swift SE, Tate SB, Nicholas J. Correlation of symptoms with degree of pelvic organ support in a general population of women: what is pelvic organ prolapse? American journal of obstetrics and gynecology. 2003;189(2):372–7. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1067/S0002-9378(03)00698-7&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=14520198&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F08%2F31%2F2024.08.30.24312827.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000185219100018&link_type=ISI) 11. 11.Aponte MM, Rosenblum N. Repair of pelvic organ prolapse: what is the goal? Current urology reports. 2014;15:1–5. 12. 12.Wiegersma M, Panman CM, Hesselink LC, Malmberg AG, Berger MY, Kollen BJ, et al. Predictors of success for pelvic floor muscle training in pelvic organ prolapse. Physical Therapy. 2019;99(1):109–17. 13. 13.Giagio S, Innocenti T, Salvioli S, Lami A, Meriggiola MC, Pillastrini P, et al. Completeness of exercise reporting among randomized controlled trials on pelvic floor muscle training for women with pelvic organ prolapse: A systematic review. Neurourology and Urodynamics. 2021;40(6):1424–32. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/nau.24712&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F08%2F31%2F2024.08.30.24312827.atom) 14. 14.Abhyankar P, Uny I, Semple K, Wane S, Hagen S, Wilkinson J, et al. Women’s experiences of receiving care for pelvic organ prolapse: a qualitative study. BMC women’s health. 2019;19:1–12. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s12905-018-0705-y&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F08%2F31%2F2024.08.30.24312827.atom) 15. 15.Hagen S, Stark D, Glazener C, Dickson S, Barry S, Elders A, et al. Individualised pelvic floor muscle training in women with pelvic organ prolapse (POPPY): a multicentre randomised controlled trial. The Lancet. 2014;383(9919):796-806. 16. 16.Abhyankar P, Wilkinson J, Berry K, Wane S, Uny I, Aitchison P, et al. Implementing pelvic floor muscle training for women with pelvic organ prolapse: a realist evaluation of different delivery models. BMC Health Services Research. 2020;20:1–16. 17. 17.Belayneh T, Gebeyehu A, Adefris M, Rortveit G, Gjerde JL, Ayele TA. Pelvic organ prolapse surgery and health-related quality of life: a follow-up study. BMC Women’s Health. 2021;21:1–11. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/S12905-021-01376-4/TABLES/4&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F08%2F31%2F2024.08.30.24312827.atom) 18. 18.Workineh ZA, Ayana BA, Gashaye KT, Wubneh SB, Kassie BA. Surgical management practice of pelvic organ prolapse among Ethiopian gynecologists, 2021: a descriptive study. BMC Women’s Health. 2023;23(1):654. 19. 19.Sung VW, Jeppson P, Madsen A. Nonoperative management of pelvic organ prolapse. Obstetrics & Gynecology. 2023;141(4):724–36. 20. 20.Footer CB, Tsegaye HS, Yitnagashaw TA, Mekonnen W, Shiferaw TD, Abera E, et al. Empowering the physiotherapy profession in Ethiopia through leadership development within the doctoring process. Frontiers in Public Health. 2017;5:51. 21. 21.(FMoHE) TFDRoE. National Health Policy. In: Health, editor. Addis Ababa2024. 22. 22.Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Bmj. 2010;340. 23. 23.Campbell MK, Piaggio G, Elbourne DR, Altman DG. Consort 2010 statement: extension to cluster randomised trials. Bmj. 2012;345. 24. 24.Siyoum M, Nardos R, Teklesilasie W, Astatkie A. Prevalence and risk factors of pelvic organ prolapse among women in Sidama region, Ethiopia: A community-based survey. Women’s Health. 2024;20:17455057241265078. 25. 25.Vértesy L, Lemango TB. Comparison of local governments in Hungary and Ethiopia. DE IURISPRUDENTIA ET IURE PUBLICO: JOG-ÉS POLITIKATUDOMÁNYI FOLYÓIRAT= JOURNAL OF LEGAL AND POLITICAL SCIENCES. 2022;13(1-2.):62-75. 26. 26.Gedefaw AA. Analysis of the contribution of land registration to sustainable land management in East Gojjam Zone, Ethiopia. Land. 2023;12(6):1157. 27. 27.Nefa SA, Ibrahim AM, Mulushewa SS, Wonga MM, Lee H-Y, Siyum GA, et al. Study design for the 2019 baseline survey of newly established longitudinal surveillance woredas as the field lab to serve child health improvement project of Benishangul-Gumuz region, Ethiopia. Journal of Global Health Science. 2019;1(2). 28. 28.Donner A, Birkett N, Buck C. Randomization by cluster: sample size requirements and analysis. American journal of epidemiology. 1981;114(6):906–14. [PubMed](http://medrxiv.org/lookup/external-ref?access_num=7315838&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F08%2F31%2F2024.08.30.24312827.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=A1981MU22700015&link_type=ISI) 29. 29.Hemming K, Eldridge S, Forbes G, Weijer C, Taljaard M. How to design efficient cluster randomised trials. bmj. 2017;358. 30. 30.Hayes RJ, Moulton LH. Cluster randomised trials: Chapman and Hall/CRC; 2017. 31. 31.Rutterford C, Copas A, Eldridge S. Methods for sample size determination in cluster randomized trials. International journal of epidemiology. 2015;44(3):1051–67. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/ije/dyv113&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=26174515&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F08%2F31%2F2024.08.30.24312827.atom) 32. 32.Roth SM, Ivey FM, Martel GF, Lemmer JT, Hurlbut DE, Siegel EL, et al. Muscle size responses to strength training in young and older men and women. Journal of the American Geriatrics Society. 2001;49(11):1428–33. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1046/j.1532-5415.2001.4911233.x&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=11890579&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2024%2F08%2F31%2F2024.08.30.24312827.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000172055100003&link_type=ISI) 33. 33.Maxwell M, Berry K, Wane S, Hagen S, McClurg D, Duncan E, et al. Pelvic floor muscle training for women with pelvic organ prolapse: the PROPEL realist evaluation. Health Services and Delivery Research. 2020;8(47). 34. 34.Hay-Smith J, Bo K, Berghmans B, Hendriks E, de Bie R, van Doorn EvW. Pelvic floor muscle training for urinary incontinence in women. The Cochrane database of systematic reviews. 2008;2008(3). 35. 35.Maxwell M, Semple K, Wane S, Elders A, Duncan E, Abhyankar P, et al. PROPEL: implementation of an evidence based pelvic floor muscle training intervention for women with pelvic organ prolapse: a realist evaluation and outcomes study protocol. BMC health services research. 2017;17:1–10. 36. 36.Women’s NCCf, Health Cs. Urinary incontinence: The management of urinary incontinence in women. 2006. 37. 37.Bø K. Pelvic floor muscle exercise for the treatment of stress urinary incontinence: an exercise physiology perspective. International Urogynecology Journal. 1995;6(5):282–91. 38. 38.Siyoum M, Teklesilasie W, Nardos R, Sirak B, Astatkie A. Reliability and validity of the Sidaamu Afoo version of the pelvic organ prolapse symptom score questionnaire. BMC Women’s Health. 2023;23(1):324. 39. 39.Hagen S, Glazener C, Sinclair L, Stark D, Bugge C. Psychometric properties of the pelvic organ prolapse symptom score. BJOG: an International Journal of Obstetrics & Gynaecology. 2009;116(1):25–31. 40. 40.Belayneh T, Gebeyehu A, Adefris M, Rortveit G, Genet T. Translation, transcultural adaptation, reliability and validation of the pelvic organ prolapse quality of life (P-QoL) in Amharic. Health and quality of life outcomes. 2019;17:1–11. 41. 41.Digesu GA, Khullar V, Cardozo L, Robinson D, Salvatore S. P-QOL: a validated questionnaire to assess the symptoms and quality of life of women with urogenital prolapse. International Urogynecology Journal. 2005;16:176–81. 42. 42.Srikrishna S, Robinson D, Cardozo L. Validation of the Patient Global Impression of Improvement (PGI-I) for urogenital prolapse. International urogynecology journal. 2010;21:523–8. 43. 43.Brækken IH, Majida M, Engh ME, Bø K. Morphological changes after pelvic floor muscle training measured by 3-dimensional ultrasonography: a randomized controlled trial. Obstetrics & Gynecology. 2010;115(2 Part 1):317-24. 44. 44.Reid F. Assessment of pelvic organ prolapse: a practical guide to the pelvic organ prolapse quantification. Obstetrics, Gynaecology & Reproductive Medicine. 2014;24(6):170–6. 45. 45.McCulloch CE, Searle SR, Neuhaus JM. Generalized, linear, and mixed models: Wiley Online Library; 2001. 46. 46.Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. Bmj. 1995;310(6973):170. 47. 47.Heeringa SG, West BT, Berglund PA. Applied survey data analysis: chapman and hall/CRC; 2017. 48. 48.Dumoulin C, Hunter KF, Moore K, Bradley CS, Burgio KL, Hagen S, et al. Conservative management for female urinary incontinence and pelvic organ prolapse review 2013: Summary of the 5th International Consultation on Incontinence. Neurourology and urodynamics. 2016;35(1):15–20. 49. 49.Hagen S, Stark D. Conservative prevention and management of pelvic organ prolapse in women. Cochrane Database of Systematic Reviews. 2011(12). 50. 50.National Institute for Health and Care Excellenceguideline NG123 N. Urinary incontinence and pelvic organ prolapse in women: management London2019 [ 51. 51.Smith A, Bevan D, Douglas HR, James D. Management of urinary incontinence in women: summary of updated NICE guidance. Bmj. 2013;347. 52. 52.Hagen S, Glazener C, Cook J, Herbison P, Toozs-Hobson P. Further properties of the pelvic organ prolapse symptom score: minimally important change and test-retest reliability. Neurourol Urodyn. 2010;29(6):1055–6. 53. 53.Ge J, Wei X, Zhang H, Fang G. Pelvic floor muscle training in the treatment of pelvic organ prolapse: A meta-analysis of randomized controlled trials. Actas Urológicas Españolas (English Edition). 2021;45(1):73–82. 54. 54.Blanchard V, Nyangoh-Timoh K, Fritel X, Fauconnier A, Pizzoferrato A-C. Importance of a pelvic floor lifestyle program in women with pelvic floor dysfunctions: A pilot study. Journal of Gynecology Obstetrics and Human Reproduction. 2021;50(4):102032. 55. 55.Wiegersma M, Panman CM, Kollen BJ, Berger MY, Lisman-Van Leeuwen Y, Dekker JH. Effect of pelvic floor muscle training compared with watchful waiting in older women with symptomatic mild pelvic organ prolapse: randomised controlled trial in primary care. Bmj. 2014;349. 56. 56.Hagen S, Glazener C, McClurg D, Macarthur C, Elders A, Herbison P, et al. Pelvic floor muscle training for secondary prevention of pelvic organ prolapse (PREVPROL): a multicentre randomised controlled trial. The lancet. 2017;389(10067):393–402. 57. 57.Borello-France DF, Handa VL, Brown MB, Goode P, Kreder K, Scheufele LL, et al. Pelvic-floor muscle function in women with pelvic organ prolapse. Physical therapy. 2007;87(4):399–407. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToicHRqb3VybmFsIjtzOjU6InJlc2lkIjtzOjg6Ijg3LzQvMzk5IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjQvMDgvMzEvMjAyNC4wOC4zMC4yNDMxMjgyNy5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 58. 58.Waterfield AE. A community study of pelvic floor muscle function in women: Exeter and Plymouth Peninsula Medical School; 2011. 59. 59.Child S, Bateman A, Shuttleworth J, Gericke C, Freeman R. Can primary care nurse administered pelvic floor muscle training (PFMT) be implemented for the prevention and treatment of urinary incontinence? A study protocol. F1000Research. 2013;2.